ID23504A - Komposi-komposi farmasi yang mengandung vitamin d dan kalsium, pembuatan dan penggunaan terapinya - Google Patents

Komposi-komposi farmasi yang mengandung vitamin d dan kalsium, pembuatan dan penggunaan terapinya

Info

Publication number
ID23504A
ID23504A IDW20000401A ID20000401A ID23504A ID 23504 A ID23504 A ID 23504A ID W20000401 A IDW20000401 A ID W20000401A ID 20000401 A ID20000401 A ID 20000401A ID 23504 A ID23504 A ID 23504A
Authority
ID
Indonesia
Prior art keywords
calcium
composions
pharmacy
therapy
making
Prior art date
Application number
IDW20000401A
Other languages
English (en)
Indonesian (id)
Inventor
Valleri Maurizio
Tosetti Alessandro
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Publication of ID23504A publication Critical patent/ID23504A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20000401A 1997-07-30 1998-07-21 Komposi-komposi farmasi yang mengandung vitamin d dan kalsium, pembuatan dan penggunaan terapinya ID23504A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97FI000184A ITFI970184A1 (it) 1997-07-30 1997-07-30 Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico

Publications (1)

Publication Number Publication Date
ID23504A true ID23504A (id) 2000-04-27

Family

ID=11352223

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000401A ID23504A (id) 1997-07-30 1998-07-21 Komposi-komposi farmasi yang mengandung vitamin d dan kalsium, pembuatan dan penggunaan terapinya

Country Status (29)

Country Link
US (1) US7067154B1 (ko)
EP (1) EP0999843B1 (ko)
JP (1) JP4497496B2 (ko)
KR (1) KR100573421B1 (ko)
AT (1) ATE271387T1 (ko)
AU (1) AU8978198A (ko)
BG (1) BG65044B1 (ko)
BR (1) BR9810832B1 (ko)
CA (1) CA2299420C (ko)
CZ (1) CZ297670B6 (ko)
DE (1) DE69825164D1 (ko)
EA (1) EA002492B1 (ko)
EE (1) EE04046B1 (ko)
ES (1) ES2223135T3 (ko)
HK (1) HK1027751A1 (ko)
HU (1) HU226112B1 (ko)
ID (1) ID23504A (ko)
IL (1) IL134268A0 (ko)
IS (1) IS5359A (ko)
IT (1) ITFI970184A1 (ko)
NO (1) NO20000310L (ko)
PL (1) PL189295B1 (ko)
PT (1) PT999843E (ko)
RS (1) RS49703B (ko)
SI (1) SI0999843T1 (ko)
SK (1) SK284873B6 (ko)
TR (1) TR200000261T2 (ko)
UA (1) UA61968C2 (ko)
WO (1) WO1999006051A1 (ko)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
ES2192136B1 (es) * 2002-01-04 2005-03-16 Italfarmaco, S.A. Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
ITFI20030194A1 (it) * 2003-07-17 2005-01-18 Menarini Int Operations Lu Sa Composizione farmaceutiche effervescenti contenenti
ES2523148T3 (es) 2004-05-24 2014-11-21 Takeda Nycomed As Material en forma de partículas que comprende un compuesto que contiene calcio y un alcohol de azúcar
NZ551692A (en) 2004-06-01 2008-12-24 Nycomed Pharma As Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
UA88943C2 (ru) 2005-02-03 2009-12-10 Нікомед Фарма Ас Быстрый способ влажного гранулирования для получения композиций, которые содержат кальций
WO2006082499A1 (en) 2005-02-03 2006-08-10 Nycomed Pharma As Melt granulation of a composition containing a calcium-containing compound
EP3047847A1 (en) * 2005-10-12 2016-07-27 OPKO Renal, LLC Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
UA95093C2 (uk) * 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
CN102872157A (zh) * 2005-12-07 2013-01-16 奈科明制药有限公司 预先压实的含钙组合物
MXPA05014091A (es) * 2005-12-20 2007-06-20 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden derivados de esteroides sinteticos, minerales y el metabolito activo de la vitamina d, 1,25(oh)2d3 (calcitriol) para la prevencion y tratamiento de la osteoporosis y el control de los sintomas de la menopaus
CA2835910C (en) * 2007-04-25 2016-06-28 Warner Chilcott Company, Llc Improved vitamin d content uniformity in pharmaceutical dosage forms
EA021707B1 (ru) 2008-11-17 2015-08-31 Такеда Никомед Ас Способ получения таблетки, содержащей по меньшей мере 50% мас./мас. карбоната кальция, и таблетка, полученная этим способом
TR200900880A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik bileşimler.
TR200900878A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
US20120015913A1 (en) 2010-07-15 2012-01-19 Delansorne Remi Formulations of 14-EPI-Analogues of Vitamin D
WO2015020191A1 (ja) * 2013-08-09 2015-02-12 日東薬品工業株式会社 カルシウム剤
CN105166935B (zh) * 2015-09-01 2018-08-31 张伟 一种含有维生素d3的液体制剂及其制备方法
SG11202010792TA (en) 2018-05-02 2020-11-27 Ferring Bv Improved pharmaceutical formulations
KR102211287B1 (ko) * 2018-12-21 2021-02-03 (주)휴온스 비타민 d 또는 이의 유도체를 포함하는 안정성이 개선된 액상 제제
EP4304569A1 (en) * 2021-03-12 2024-01-17 Nicoventures Trading Limited Oral products with self-emulsifying system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073271A1 (en) * 1969-12-11 1971-10-01 Boivin Jean Calcium salt - vitamin d2 compn - for treatment of decalcification of
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
DK8603837A (ko) * 1985-08-13 1987-02-14
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
WO1991011117A2 (en) * 1990-02-05 1991-08-08 Board Of Regents, The University Of Texas System Dietary supplements comprising vitamins and minerals
DE69122099T2 (de) * 1990-05-16 1997-04-17 Margaret Hanausek Zusammensetzung und verfahren zur prävention und behandlung von hypercholesterinämie und zellproliferationsstorungen
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
IL103224A (en) * 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
FR2724844B1 (fr) * 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
FR2760639B1 (fr) * 1997-03-14 2000-09-22 Innothera Lab Sa Association therapeutique mineralo-vitaminique sous forme de preparation unitaire liquide buvable

Also Published As

Publication number Publication date
JP4497496B2 (ja) 2010-07-07
WO1999006051A1 (en) 1999-02-11
EA200000181A1 (ru) 2000-10-30
BR9810832B1 (pt) 2010-11-16
CA2299420A1 (en) 1999-02-11
HUP0100539A2 (hu) 2001-08-28
TR200000261T2 (tr) 2000-09-21
NO20000310D0 (no) 2000-01-21
DE69825164D1 (de) 2004-08-26
UA61968C2 (en) 2003-12-15
EE04046B1 (et) 2003-06-16
YU3700A (sh) 2002-11-15
SI0999843T1 (en) 2005-02-28
US7067154B1 (en) 2006-06-27
CA2299420C (en) 2009-04-21
ES2223135T3 (es) 2005-02-16
CZ2000199A3 (cs) 2000-05-17
HK1027751A1 (en) 2001-01-23
ITFI970184A1 (it) 1999-01-30
EA002492B1 (ru) 2002-06-27
HU226112B1 (en) 2008-04-28
AU8978198A (en) 1999-02-22
PT999843E (pt) 2004-11-30
BR9810832A (pt) 2000-07-25
KR20010022319A (ko) 2001-03-15
SK802000A3 (en) 2000-07-11
KR100573421B1 (ko) 2006-04-26
IS5359A (is) 2000-01-24
ATE271387T1 (de) 2004-08-15
JP2001511453A (ja) 2001-08-14
BG104057A (en) 2000-07-31
EP0999843A1 (en) 2000-05-17
CZ297670B6 (cs) 2007-02-28
SK284873B6 (sk) 2006-01-05
EP0999843B1 (en) 2004-07-21
BG65044B1 (bg) 2007-01-31
IL134268A0 (en) 2001-04-30
NO20000310L (no) 2000-01-21
PL189295B1 (pl) 2005-07-29
RS49703B (sr) 2007-12-31
PL338237A1 (en) 2000-10-09
EE200000054A (et) 2000-10-16

Similar Documents

Publication Publication Date Title
ID23504A (id) Komposi-komposi farmasi yang mengandung vitamin d dan kalsium, pembuatan dan penggunaan terapinya
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
HUP9802448A3 (en) Inhibitors of platelet aggregation, preparation and use thereof and pharmaceutical compositions
FI962154A0 (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
AU4879396A (en) Use of inorganic aerogels in pharmacy
BR0112094A (pt) Produtos de confeitaria contendo ingredientes ativos
CA2132369A1 (en) Use for the Treatment of Mixed Skins, of an Effective Quantity of Active Substances
AU6076198A (en) Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
HUP9801880A3 (en) Novel cryptophycins, their use and pharmaceutical compositions containing them
TNSN97031A1 (fr) Melanges insolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments.
SE9802937D0 (sv) Novel compounds
EP0659403A3 (en) Use of natural oil-absorbing polymer in cosmetic and pharmaceutical applications.
FR2730636B1 (fr) Huile vegetale naturelle enrichie en ozonides, compositions cosmetiques ou pharmaceutiques la contenant et utilisations
ID22416A (id) Komposisi-komposisi farmasi yang mengandung ibuprofen dan domperidon untuk pengobatan migrain
ID16081A (id) Penggunaan turunan trisiklik dari 1,4-dihidro-1,4-diokso-1h-naftalena senyawa-senyawa yang diperolehnya dan penerapannya dalam terapi
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
ES2150373A1 (es) Capsulas de gelatina blanda que contienen aceite de oliva.
AU2811400A (en) Stable formulation containing fumagillin
ZA9711734B (en) Novel farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments.
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
FR2684299B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.
WO1999003509A3 (de) Pharmazeutische mittel enthaltend perfluoralkylgruppenhaltige trijodaromaten und ihre verwendung in der tumortherapie und interventionellen radiologie
FR2740039B1 (fr) Utilisation d'une substance inhibant la proteine d'adhesion d'un microorganisme, composition notamment cosmetique ou therapeutique contenant cette substance
HUT75711A (en) The use of dimeticone as a transport and carrier system and/or drug delivery system, and pharmaceutical compositions containing dimeticone